Cargando…

Do Myositis-Specific Antibodies have Specific Histopathological Marks?

Detalles Bibliográficos
Autor principal:	Katirji, Bashar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645231/ https://www.ncbi.nlm.nih.gov/pubmed/37970247 http://dx.doi.org/10.4103/aian.aian_486_23

Ejemplares similares

Clinical Significance of Myositis-Specific and Myositis-Associated Antibody Profiles in Dermatomyositis
por: Babu, Anuradha K., et al.
Publicado: (2022)

Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study
por: Sambataro, Gianluca, et al.
Publicado: (2023)

Myositis-specific Antibodies: Overview and Clinical Utilization
por: Halilu, Fatima, et al.
Publicado: (2022)

Immune Checkpoint Glycoproteins Have Polymorphism: Are Monoclonal Antibodies Too Specific?
por: Jalalizadeh, Mehrsa, et al.
Publicado: (2023)

The Association of Myositis Specific Antibodies in Patients with Inflammatory Myositis: Preliminary Data in Indian Patients
por: Negalur, Natasha Vijay, et al.
Publicado: (2021)

Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease
por: Mammen, Andrew L., et al.
Publicado: (2015)

Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies
por: Mahler, Michael, et al.
Publicado: (2019)

How Do We Interpret the Presence of Donor-Specific Antibodies When There Is No Rejection?
por: Crew, R. John, et al.
Publicado: (2019)

What do biomarkers mark?
por: Öngen, Zeki
Publicado: (2016)

Coexistence of Multiple Myositis-Specific Antibodies in Patients with Idiopathic Inflammatory Myopathies
por: Huang, Hung-Ling, et al.
Publicado: (2022)

A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies
por: Sambataro, Gianluca, et al.
Publicado: (2022)

In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
por: Chinoy, Hector, et al.
Publicado: (2006)

Utilization of myositis antibody-specific panel for diagnosis, treatment, and evaluation of disease progression
por: Stark, Ana, et al.
Publicado: (2020)

TB or not to be: what specificities and impact do antibodies have during tuberculosis?
por: Hermann, Clemens, et al.
Publicado: (2021)

The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis
por: Tansley, Sarah L., et al.
Publicado: (2020)

Do bronchodilators have an effect on bronchiolitis?
por: Schindler, Margrid
Publicado: (2002)

Time-restricted feeding: what we have done and what more we can do?
por: Sun, Yuning, et al.
Publicado: (2023)

Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
por: Misra, Abhinav K., et al.
Publicado: (2021)

Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies
por: Mahler, Michael, et al.
Publicado: (2021)

Practical approach to electrodiagnosis of the carpal tunnel syndrome: A review
por: Basiri, Keivan, et al.
Publicado: (2015)

Unihemispheric central nervous system vasculitis
por: Thanaviratananich, Sikawat, et al.
Publicado: (2017)

Myositis-specific autoantibodies: detection and clinical associations
por: van Dooren, Sander H. J., et al.
Publicado: (2011)

Myositis Specific Autoantibodies: A Clinical Perspective
por: Alenzi, Fahidah M
Publicado: (2020)

The Role of Myositis-Specific Autoantibodies in the Dermatomyositis Spectrum
por: Marasandra Ramesh, Harshita, et al.
Publicado: (2022)

Clinical and histopathological features of myositis in systemic lupus erythematosus
por: Tiniakou, Eleni, et al.
Publicado: (2022)

Antigen-specific immunotherapy for MOG antibody-associated diseases
por: Nessler, Stefan
Publicado: (2019)

Recent data and developments in myositis
por: Stenzel, Werner, et al.
Publicado: (2021)

Who knew? The misleading specificity of “double-blind” and what to do about it
por: Lang, Thomas A., et al.
Publicado: (2020)

The skin myositis Delphi group puts the details in ‘skin‐predominant’ dermatomyositis
por: Fernandez, Anthony P.
Publicado: (2019)

What should we expect when two myositis-specific antibodies coexist in a patient
por: Zheng, Yiming, et al.
Publicado: (2023)

Do We Have a Channel Solution for ALS?
por: de Carvalho, Mamede
Publicado: (2015)

Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies
por: Okiyama, Naoko, et al.
Publicado: (2019)

Serum Specific Antibodies Do Not Seem to Have an Additional Role in the Diagnosis of Hypersensitivity Pneumonitis
por: Demirkol, Baris, et al.
Publicado: (2023)

Summative peer marking?
por: O’Neill, Lotte, et al.
Publicado: (2016)

One size fits all, or do we have to rethink optimal programming in implantable cardioverter-defibrillators implanted for secondary prevention?
por: Cakulev, Ivan, et al.
Publicado: (2020)

Antibodies against oxidation-specific epitopes and risk of acute myocardial infarction
por: Frostegård, Johan
Publicado: (2023)

The Eyes Have It—Or Do They?
por: Lewallen, Susan, et al.
Publicado: (2017)

Do arrestin oligomers have specific functions?
por: Gurevich, Vsevolod V.
Publicado: (2023)

The Schwartz-Jampel syndrome: Case report and review of literature
por: Basiri, Keivan, et al.
Publicado: (2015)

Do statins have a role in preventing or treating sepsis?
por: Novack, Victor, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_kl9sb0gp88tpj3msl9h0ffsjo4